TON - March 2017, Vol 10, No 2

The Mass General Cancer Center is among the leading cancer care providers in the United States, and is a National Cancer Institute–designated comprehensive cancer center as part of the 7-member Harvard Medical School consortium.
Surviving cancer is the start of a new journey for many individuals. Cancer survivors face a multitude of challenges, including prevention of new and recurrent cancers; interventions for illnesses secondary to cancer and its treatment; concerns related to employment, insurance, and disability; and coordination between specialists and primary care providers.
A Direct Access Screening Colonoscopy (DASC) program at Advocate Illinois Masonic Medical Center in Chicago was found to increase the overall screening rate for colorectal cancer (CRC) by almost 100% without excess complications.
The largest study to date comparing outcomes of radiation therapy and postmastectomy breast reconstruction found higher rates of complication and failure in women who received radiation therapy and had implant reconstruction versus autologous reconstruction.
What to expect in this month's issue of The Oncology Nurse APN/PA
Thyroid cancer represents only 3.8% of new cancer cases annually in the United States, but occurs approximately 3 times as often in women as in men.
Daily moderate physical activity can improve outcomes in patients with metastatic colorectal cancer (CRC).
Overwhelming evidence supports a chemopreventive benefit of aspirin on colo­rectal cancer (CRC), and a potential effect on other cancers and cardiovascular risk.
Screening of colorectal cancer (CRC) tumors for mismatch repair (MMR) deficiency has been shown to increase the identification of patients with Lynch syndrome.
  • Venetoclax plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Adding Antiandrogen to Radiation Therapy Extends Survival in Relapsed Prostate Cancer
Page 1 of 3
Results 1 - 10 of 22